The impact of the duration of an untreated episode on improvement of depression and somatic symptoms

References

• GhioLGotelliSMarcenaroMAmoreMNattaWDuration of untreated illness and outcomes in unipolar depression: a systematic review and meta-analysisJ Affect Disord2014152–1544551
   PubMed Web of Science ®Google Scholar
• BukhJDBockCVinbergMKessingLVThe effect of prolonged duration of untreated depression on antidepressant treatment outcomeJ Affect Disord20131451424822854096
   PubMed Web of Science ®Google Scholar
• OkudaASuzukiTKishiTDuration of untreated illness and antidepressant fluvoxamine response in major depressive disorderPsychiatry Clin Neurosci201064326827320602727
   PubMed Web of Science ®Google Scholar
• de Diego-AdelinoJPortellaMJPuigdemontDPerez-EgeaRAlvarezEPerezVA short duration of untreated illness (DUI) improves response outcomes in first-depressive episodesJ Affect Disord20101201–322122519349077
   PubMed Web of Science ®Google Scholar
• AltamuraACBuoliMAlbanoADell’OssoBAge at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic studyInt Clin Psychopharmacol201025317217920305566
   PubMed Web of Science ®Google Scholar
• AltamuraADell’ossoBVismaraSMundoEMay duration of untreated illness influence the long-term course of major depressive disorder?Eur Psychiatry2008232929618248964
   PubMed Web of Science ®Google Scholar
• AltamuraACDell’OssoBMundoEDell’OssoLDuration of untreated illness in major depressive disorder: a naturalistic studyInt J Clin Pract200761101697170017877655
   PubMed Web of Science ®Google Scholar
• NovickDMontgomeryWAguadoJWhich somatic symptoms are associated with an unfavorable course in Asian patients with major depressive disorder?J Affect Disord20131491–318218823521872
   PubMed Web of Science ®Google Scholar
• HungCILiuCYWangSJYangCHResidual symptoms related to physical and panic symptoms at baseline predict remission of depression at follow-upPsychopathology2014471515623652027
   PubMed Web of Science ®Google Scholar
• HungCILiuCYWangSJJuangYYYangCHSomatic symptoms: an important index in predicting the outcome of depression at six-month and two-year follow-up points among outpatients with major depressive disorderJ Affect Disord20101251–313414020064663
   PubMed Web of Science ®Google Scholar
• KöhlerSUngerTHoffmannSMackertARossBFydrichTThe relationship of health-related quality of life and treatment outcome during inpatient treatment of depressionQual Life Res201532464164925240747
   PubMed Web of Science ®Google Scholar
• NovickDMontgomeryWKadziolaZDo concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?Patient Prefer Adherence2013746347023818764
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text RevisionWashington, DCAmerican Psychiatric Association2000
   Google Scholar
• FirstMBSpitzerRLGibbonMWilliamsJBWStructured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P)New YorkBiometrics Research, New York State Psychiatric Institute2002
   Google Scholar
• HamiltonMDevelopment of a rating scale for primary depressive illnessBr J Soc Clin Psychol1967642782966080235
   PubMedGoogle Scholar
• HungCIWengLJSuYJLiuCYDepression and Somatic Symptoms Scale: a new scale with both depression and somatic symptoms emphasizedPsychiatry Clin Neurosci200660670070817109704
   PubMed Web of Science ®Google Scholar
• HungCIWangSJLiuCYValidation of the Depression and Somatic Symptoms Scale (DSSS) by comparison with the Short Form 36 (SF-36) scale among psychiatric outpatients with major depressive disorderDepress Anxiety200926658359119242983
   PubMed Web of Science ®Google Scholar
• HungCILiuCYWangSJYaoYCYangCHThe cut-off points of the Depression and Somatic Symptoms Scale and the Hospital Anxiety and Depression Scale in detecting non-full remission and a current major depressive episodeInt J Psychiatry Clin Pract2012161334022122659
   PubMed Web of Science ®Google Scholar
• HungCIWangSJLiuCYHsuSCYangCHComorbidities and factors related to discontinuation of pharmacotherapy among outpatients with major depressive disorderCompr Psychiatry201152437037721683174
   PubMed Web of Science ®Google Scholar
• SapolskyRMUnoHRebertCSFinchCEHippocampal damage associated with prolonged glucocorticoid exposure in primatesJ Neurosci1990109289729022398367
   PubMed Web of Science ®Google Scholar
• KemptonMJSalvadorZMunafòMRStructural neuroimaging studies in major depressive disorder: meta-analysis and comparison with bipolar disorderArch Gen Psychiatry201168767569021727252
   PubMed Web of Science ®Google Scholar
• VidebechPRavnkildeBHippocampal volume and depression: a meta-analysis of MRI studiesAm J Psychiatry2004161111957196615514393
   PubMed Web of Science ®Google Scholar
• MalbergJEEischAJNestlerEJDumanRSChronic antidepressant treatment increases neurogenesis in adult rat hippocampusJ Neurosci200020249104911011124987
   PubMed Web of Science ®Google Scholar
• PosternakMASolomonDALeonACThe naturalistic course of unipolar major depression in the absence of somatic therapyJ Nerv Ment Dis2006194532432916699380
   PubMed Web of Science ®Google Scholar
• TrivediMHRushAJWisniewskiSREvaluation of outcomes With citalopram for depression using measurement-based care in STAR*D: implications for clinical practiceAm J Psychiatry20061631284016390886
   PubMed Web of Science ®Google Scholar
• PreskornSheldon HWhat do the terms “drug-specific response/remission rate” and “placebo” really mean?J Psychiatry Pract2011176420424
   Web of Science ®Google Scholar
• FriedmanESDavisLLZisookSBaseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trialEur Neuropsychopharmacol201232218319921920711
   PubMed Web of Science ®Google Scholar
• CrismonMLTrivediMPigottTAThe Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive DisorderJ Clin Psychiatry199960314215610192589
   PubMed Web of Science ®Google Scholar
• QuitkinFMMcGrathPJStewartJWChronological milestones to guide drug change. When should clinicians switch antidepressants?Arch Gen Psychiatry19965397857928792755
   PubMed Web of Science ®Google Scholar
• TedeschiniEFavaMPapakostasGIPlacebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks’ duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approachJ Clin Psychiatry20117219811321208576
   PubMed Web of Science ®Google Scholar